Special Events*

Wednesday August 14, 1:45pm – 3:50pm

Advances in Gene and Cell Therapy

1.45 – 1.50 pm Introduction

Barry Buckland, PhD, Executive Director, NIIMBL

1.50 – 2.00 pm NIIMBL Overview

Ruben Carbonell, PhD, Chief Technology Officer, NIIMBL

2.00 – 2.25 pm Engineering a Scalable Producer Cell Line to Support AAV Manufacturing

Jen Baerenwald, PhD, Scientist I, Biogen

2.25 – 2.55 pm Global Manufacturing of CAR T Cell Therapy, Transition from the Clinic to Commercial Manufacturing

Bruce Levine, PhD, Barbara and Edward Netter Professor, Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine

2.55 – 3.20 pm Output from Recent Workshop at ECI Conference on Advancing Manufacture of Cell and Gene Therapies VI
Practical Considerations for Viral Vector Manufacturing - Is Continuous Bioprocessing the Future?

Fernanda Masri, PhD, Technology Expert for Regenerative Medicine, Sartorius Stedim

3.20 – 3.50 pm Thoughts on the Future of Cell Therapy Manufacturing and Delivery

Jason Martin, Executive Director, Site Head of Warren Manufacturing, Cell Therapy Development & Operations, Celgene Corporation

For Speaker Bios, please visit https://www.bioprocessingsummit.com/Speaker-Biographies#SE-NIIMBL

EVENTS SCHEDULE

1:45 - 3:50            Special Events

3:50 - 4:45            Networking Refreshment Break in the Exhibit Hall with Poster Viewing

4:45 - 6:00            Plenary Keynote Session

6:00 - 7:00            A Taste of New England Reception in the Exhibit Hall with Poster Viewing

* Requires a Main Conference or Exhibit Hall Visitor Pass to attend. Pre-registration encouraged due to limited spaces available.

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership dedicated to advancing U.S. competitiveness in the biopharmaceutical manufacturing industry through technology advancement and workforce training. It’s 100+ members collaborate in a precompetitive environment on technologies that will bring safe, efficacious products to market faster and with reduce costs. The NIIMBL mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry.

NIIMBL is part of Manufacturing USA®, a network of 14 manufacturing institutes across the country that brings together industry, academia, and the public sector to propel promising research developments, accelerate new products to market, and train tomorrow’s workforce in order to secure America’s future.